🔎 Trials Near Me

Hjem › Lungekreft › California › Concord

Kliniske studier for Lungekreft i Concord, CA

9 studier for Lungekreft søker deltakere på steder i og rundt Concord (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RekruttererFase 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi unna
  • John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

RekruttererFase 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT04181060

Distance-Based Exercise to Preserve Function and Prevent Disability

Rekrutterer
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • John Muir Medical Center-Walnut Creek, Walnut Creek · 5 mi unna
  • Contra Costa Regional Medical Center, Martinez · 6 mi unna
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RekruttererFase 3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06498635

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

RekruttererFase 2/3
  • John Muir Clinical Research Center, Concord
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06712316

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RekruttererFase 3
  • BASS Cancer Center, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

RekruttererFase 2
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

RekruttererFase 2/3
  • Kaiser Permanente-Walnut Creek, Walnut Creek · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 5. mai 2026 · NCT06616584

Lungekreft-studier i andre byer

Andre studier i Concord

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.